Sophiris Bio Company Profile (NASDAQ:SPHS)

About Sophiris Bio

Sophiris Bio logoSophiris Bio, Inc., formerly Protox Therapeutics Inc., is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases. The Company has operations based in San Diego developing a treatment for benign prostatic hyperplasia (benign prostatic hyperplasia (BPH) or enlarged prostate). The Company has partnered with Kissei Pharmaceuticals for the development and commercialization of PRX302 in Japan. Sophiris Bio, Inc. is advancing a pipeline of receptor targeted fusion proteins based on three complementary technology platforms: PORxin, INxin and HUMxin. It focuses on diseases of the prostate via its PORxin platform candidate, PRX302, which has completed three clinical trials for the treatment of BPH, as well as two clinical trials for the treatment of localized recurrent prostate cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SPHS
  • CUSIP:
Key Metrics:
  • Previous Close: $2.79
  • 50 Day Moving Average: $2.84
  • 200 Day Moving Average: $3.15
  • 52-Week Range: $30,107,000.00 - $0.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.00
  • P/E Growth: 0.00
  • Market Cap: $83.10M
  • Outstanding Shares: 30,107,000
  • Beta: 1.75
Profitability:
  • Return on Equity: -295.87%
  • Return on Assets: -91.49%
Debt:
  • Current Ratio: 16.20%
  • Quick Ratio: 16.20%
Additional Links:
Companies Related to Sophiris Bio:

Analyst Ratings

Consensus Ratings for Sophiris Bio (NASDAQ:SPHS) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (135.51% upside)

Analysts' Ratings History for Sophiris Bio (NASDAQ:SPHS)
Show:
DateFirmActionRatingPrice TargetDetails
11/11/2016Roth CapitalReiterated RatingBuy$8.00View Rating Details
8/30/2016Piper Jaffray CompaniesInitiated CoverageOverweight -> Overweight$7.00View Rating Details
8/10/2016Maxim GroupBoost Price TargetBuy$4.00 -> $6.00View Rating Details
6/10/2016Echelon Wealth PartnersReiterated RatingBuy$5.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Sophiris Bio (NASDAQ:SPHS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/21/2017        
5/16/2016Q1($0.19)($0.13)ViewN/AView Earnings Details
3/23/2016Q4($0.15)ViewN/AView Earnings Details
11/16/2015Q3($0.22)ViewN/AView Earnings Details
5/13/2015($0.30)($0.26)ViewN/AView Earnings Details
3/10/2015($0.47)($0.31)ViewN/AView Earnings Details
11/13/2014($0.54)($0.49)ViewN/AView Earnings Details
5/13/2014Q114($0.50)($0.52)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sophiris Bio (NASDAQ:SPHS)
Current Year EPS Consensus Estimate: $-0.55 EPS
Next Year EPS Consensus Estimate: $-0.46 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20162($0.09)($0.07)($0.08)
Q4 20162($0.08)($0.06)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sophiris Bio (NASDAQ:SPHS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sophiris Bio (NASDAQ:SPHS)
Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 5.99%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2014Boxer Capital, LlcMajor ShareholderSell881,479$0.61$537,702.19View SEC Filing  
11/14/2014Randall E WoodsInsiderBuy3,000$2.43$7,290.00View SEC Filing  
9/19/2014Gerald T ProehlDirectorBuy10,000$3.16$31,600.00View SEC Filing  
7/10/2014Randall E WoodsInsiderBuy1,000$2.65$2,650.00View SEC Filing  
7/9/2014Randall E WoodsInsiderBuy1,000$2.66$2,660.00View SEC Filing  
6/6/2014James L HeppellDirectorSell19,231$2.59$49,808.29View SEC Filing  
8/22/2013Randall E WoodsCEOBuy2,500$4.50$11,250.00View SEC Filing  
8/20/2013Peter T SloverCFOBuy4,680$4.25$19,890.00View SEC Filing  
8/19/2013Randall E WoodsCEOBuy10,000$4.29$42,900.00View SEC Filing  
8/16/2013Boxer Capital, LlcMajor ShareholderBuy1,600,000$5.00$8,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sophiris Bio (NASDAQ:SPHS)
DateHeadline
News IconAnalysts Are Sizing Up Sophiris Bio, Inc. (NASDAQ:SPHS): Where Does the Sell-Side See It Going? - Winfield Review (NASDAQ:SPHS)
winfieldreview.com - February 20 at 8:49 AM
News IconSophiris Bio Inc SPHS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:SPHS)
www.bioportfolio.com - February 13 at 12:51 AM
News IconRange Watch on Technical Indicators for Sophiris Bio Inc. (SPHS ... - Davidson Register (NASDAQ:SPHS)
davidsonregister.com - February 11 at 3:21 AM
News IconReviewing Indicator Levels for Sophiris Bio Inc. (SPHS) - Sherwood Daily (NASDAQ:SPHS)
sherwooddaily.com - February 4 at 2:17 AM
News IconInvestor Sphere: Keeping an Eye on Levels for Sophiris Bio Inc. (SPHS) - Sherwood Daily (NASDAQ:SPHS)
sherwooddaily.com - February 3 at 5:33 AM
News IconCan This Stock Grab Upward Traction: Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - January 30 at 10:07 PM
News IconIs There Inherent Value in Sophiris Bio, Inc. (NASDAQ:SPHS)? Analysts Delve Into The Stock - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 30 at 10:07 PM
finance.yahoo.com logoSophiris Bio to Webcast Live Presentation at BetterInvesting's Virtual Investor Conference - Yahoo Finance (NASDAQ:SPHS)
finance.yahoo.com - January 30 at 10:07 PM
News IconStock Monitor: Sophiris Bio, Inc. (NASDAQ:SPHS) A look at the Shares - Aiken Advocate (NASDAQ:SPHS)
aikenadvocate.com - January 30 at 10:07 PM
News IconPeeling Back The Layers on Sophiris Bio, Inc. (NASDAQ:SPHS): Analysts & Street Weigh In - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 30 at 10:07 PM
finance.yahoo.com logoSophiris Bio to Webcast Live Presentation at BetterInvesting's Virtual Investor Conference (NASDAQ:SPHS)
finance.yahoo.com - January 30 at 10:07 PM
News IconSignal Watch: Checking the Numbers for Sophiris Bio Inc. (SPHS) - Sherwood Daily (NASDAQ:SPHS)
sherwooddaily.com - January 23 at 9:46 PM
News IconPT Notice & Review for Sophiris Bio, Inc. (NASDAQ:SPHS) - Aiken Advocate (NASDAQ:SPHS)
aikenadvocate.com - January 22 at 7:40 PM
investornewswire.com logoSophiris Bio, Inc. (NASDAQ:SPHS) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:SPHS)
www.investornewswire.com - January 21 at 7:40 PM
News IconPT Review for Sophiris Bio, Inc. (NASDAQ:SPHS) - Aiken Advocate (NASDAQ:SPHS)
aikenadvocate.com - January 21 at 7:40 PM
News IconSophiris Bio, Inc. (NASDAQ:SPHS) Closed the Last Trading Session with increase of 11.38% - The Newburgh Press (NASDAQ:SPHS)
newburghpress.com - January 21 at 7:40 PM
investing.com logoSophiris Bio Inc (SPHS) (NASDAQ:SPHS)
www.investing.com - January 20 at 6:50 AM
News IconStock to Watch: Sophiris Bio Inc. (SPHS) - Sherwood Daily (NASDAQ:SPHS)
sherwooddaily.com - January 18 at 11:35 PM
News IconAre Analysts Pounding the Table on Sophiris Bio, Inc. (NASDAQ:SPHS) In 2017? - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 18 at 11:35 PM
News IconCan This Stock Make a Ripple in the Market: Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - January 18 at 11:35 PM
News IconLive Stock Coverage: Today Sophiris Bio Inc Stock Rises - Fair View Times (NASDAQ:SPHS)
fairviewtimes.com - January 18 at 11:35 PM
News IconTrading Roundup: Checking Technicals for Sophiris Bio Inc. (SPHS) - Sherwood Daily (NASDAQ:SPHS)
sherwooddaily.com - January 17 at 12:44 PM
News IconCan This Stock Gain Traction: Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - January 17 at 12:44 PM
News IconSell-side Predictions for Sophiris Bio, Inc. (NASDAQ:SPHS) - Aiken Advocate (NASDAQ:SPHS)
aikenadvocate.com - January 16 at 1:15 PM
News IconBoom or Bust? Is there any value in Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - January 16 at 1:15 PM
investornewswire.com logoSophiris Bio, Inc. (NASDAQ:SPHS) Strong Sell Recommendations At {RATING_CNT_STRONG_SELLS:378}} - Investor Newswire (NASDAQ:SPHS)
www.investornewswire.com - January 15 at 1:00 AM
News IconPrimed For An Earnings Beat? Sell-side Chimes in on Sophiris Bio, Inc. (NASDAQ:SPHS) Stock - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 14 at 6:20 AM
News IconAre Discerning Investors Interested in These Shares: Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - January 12 at 10:40 PM
News IconNews Impact Score Of Sophiris Bio, Inc. (NASDAQ:SPHS) Set At 0 - Stock Observer (NASDAQ:SPHS)
www.thestockobserver.com - January 12 at 10:40 PM
News IconStock Edging Lower Out Of The Gate: Sophiris Bio, Inc. (NASDAQ:SPHS) - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 12 at 10:40 PM
News IconWall Street and Armchair Analysts Weigh in on Sophiris Bio, Inc. (NASDAQ:SPHS) Heading Into The New Year - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 12 at 10:40 PM
News IconWhat's Are Analysts Expecting of Sophiris Bio, Inc. (NASDAQ:SPHS) In 2017? - Wall Street Beacon (NASDAQ:SPHS)
wsbeacon.com - January 12 at 12:55 AM
News IconNotable Stock For Under $5: Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - January 10 at 4:19 AM
investornewswire.com logoSophiris Bio, Inc. (NASDAQ:SPHS) Strong Buy Recommendations At 2 - Investor Newswire (NASDAQ:SPHS)
www.investornewswire.com - January 1 at 12:45 AM
News IconSophiris Bio, Inc. (NASDAQ:SPHS) News Impact Score At 0 - Stock Observer (NASDAQ:SPHS)
www.thestockobserver.com - December 30 at 12:53 AM
News IconAre the Technicals Adding up for Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - December 23 at 3:27 PM
News IconCheap Stock Alert on Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - December 20 at 7:51 PM
News IconMeasuring the Levels on Shares of Sophiris Bio Inc. (SPHS) - Yankee Analysts (NASDAQ:SPHS)
yankeeanalysts.com - December 17 at 1:12 AM
News IconUpside Alert: Delving into Shares of Sophiris Bio, Inc. (NASDAQ:SPHS) - Prospect Journal (NASDAQ:SPHS)
prospectjournal.com - December 12 at 8:01 PM
capitalcube.com logoSophiris Bio, Inc. :SPHS-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 (NASDAQ:SPHS)
www.capitalcube.com - December 1 at 7:49 PM
News IconSophiris Bio, Inc. (NASDAQ:SPHS) reported Market Capitalization of 90.63 Million - The Newburgh Press (NASDAQ:SPHS)
newburghpress.com - November 30 at 10:38 AM
investornewswire.com logoCan Shares Of Sophiris Bio, Inc. (NASDAQ:SPHS) Hit $8? - Investor Newswire (NASDAQ:SPHS)
www.investornewswire.com - November 26 at 3:48 PM
News IconHeadlining Penny Stock: In Focus Sophiris Bio, Inc. (NASDAQ:SPHS) - Duncan Research (NASDAQ:SPHS)
www.duncanindependent.com - November 26 at 12:18 PM
News IconCCI Level Check for Sophiris Bio Inc. (SPHS) - MicroCap Wired (NASDAQ:SPHS)
www.microcapwired.com - November 26 at 12:18 PM
News IconTrading Watch: ADX and CCI Review for Sophiris Bio Inc. (SPHS) - MicroCap Wired (NASDAQ:SPHS)
www.microcapwired.com - November 24 at 7:34 PM
News IconWhat The Charts Are Saying About Sophiris Bio, Inc. (NASDAQ:SPHS) - Wall Street Lion (NASDAQ:SPHS)
wslnews.com - November 23 at 10:50 AM
News IconTraders are Following Technical Levels for Sophiris Bio Inc. (SPHS) - MicroCap Wired (NASDAQ:SPHS)
www.microcapwired.com - November 22 at 7:46 PM
News IconWonder Stock Alert: Investors Curious About Sophiris Bio, Inc. (NASDAQ:SPHS) - Duncan Research (NASDAQ:SPHS)
www.duncanindependent.com - November 22 at 7:46 PM
finance.yahoo.com logoSophiris Bio to Present at 28th Annual Piper Jaffray Healthcare Conference (NASDAQ:SPHS)
finance.yahoo.com - November 22 at 12:13 PM
News IconSophiris Bio, Inc. SPHS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:SPHS)
www.bioportfolio.com - November 21 at 8:02 PM

Social

What is Sophiris Bio's stock symbol?

Sophiris Bio trades on the NASDAQ under the ticker symbol "SPHS."

Where is Sophiris Bio's stock going? Where will Sophiris Bio's stock price be in 2017?

4 brokerages have issued 1 year price targets for Sophiris Bio's stock. Their predictions range from $5.00 to $8.00. On average, they expect Sophiris Bio's share price to reach $6.50 in the next year.

When will Sophiris Bio announce their earnings?

Sophiris Bio is scheduled to release their next quarterly earnings announcement on Tuesday, March, 21st 2017.

Who owns Sophiris Bio stock?

Sophiris Bio's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Palo Alto Investors LLC (0.82%) and Oxford Asset Management (0.58%).

Who bought Sophiris Bio stock? Who is buying Sophiris Bio stock?

Sophiris Bio's stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management.

How do I buy Sophiris Bio stock?

Shares of Sophiris Bio can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Sophiris Bio stock cost?

One share of Sophiris Bio stock can currently be purchased for approximately $2.76.

Sophiris Bio (NASDAQ:SPHS) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Sophiris Bio (NASDAQ:SPHS)

Earnings History Chart

Earnings by Quarter for Sophiris Bio (NASDAQ:SPHS)

Dividend History Chart

Dividend Payments by Quarter for Sophiris Bio (NASDAQ:SPHS)

Last Updated on 2/20/2017 by MarketBeat.com Staff